The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA1493046
Max Phase: Preclinical
Molecular Formula: C19H23FN2O
Molecular Weight: 314.40
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: Cc1cc(C(=O)CN2CCCCC2)c(C)n1-c1ccc(F)cc1
Standard InChI: InChI=1S/C19H23FN2O/c1-14-12-18(19(23)13-21-10-4-3-5-11-21)15(2)22(14)17-8-6-16(20)7-9-17/h6-9,12H,3-5,10-11,13H2,1-2H3
Standard InChI Key: RYIVINSSPOAIBA-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 314.40Molecular Weight (Monoisotopic): 314.1794AlogP: 3.90#Rotatable Bonds: 4Polar Surface Area: 25.24Molecular Species: NEUTRALHBA: 3HBD: 0#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0CX Acidic pKa: CX Basic pKa: 7.01CX LogP: 3.78CX LogD: 3.63Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.80Np Likeness Score: -2.24
References 1. PubChem BioAssay data set, 2. Li P, Liu HM.. (2020) Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors., 191 [PMID:32092586 ] [10.1016/j.ejmech.2020.112107 ]